Regent Investment Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.29M | Hold |
2,515
| – | – | 0.35% | 81 |
|
|
2022
Q3 | $1.14M | Hold |
2,515
| – | – | 0.33% | 84 |
|
|
2022
Q2 | $1.21M | Hold |
2,515
| – | – | 0.34% | 82 |
|
|
2022
Q1 | $1.24M | Hold |
2,515
| – | – | 0.29% | 88 |
|
|
2021
Q4 | $1.17M | Hold |
2,515
| – | – | 0.25% | 96 |
|
|
2021
Q3 | $938K | Hold |
2,515
| – | – | 0.22% | 102 |
|
|
2021
Q2 | $960K | Hold |
2,515
| – | – | 0.23% | 99 |
|
|
2021
Q1 | $903K | Hold |
2,515
| – | – | 0.23% | 96 |
|
|
2020
Q4 | $808K | Hold |
2,515
| – | – | 0.22% | 95 |
|
|
2020
Q3 | $676K | Hold |
2,515
| – | – | 0.21% | 95 |
|
|
2020
Q2 | $661K | Hold |
2,515
| – | – | 0.22% | 95 |
|
|
2020
Q1 | $571K | Hold |
2,515
| – | – | 0.24% | 95 |
|
|
2019
Q4 | $760K | Hold |
2,515
| – | – | 0.23% | 102 |
|
|
2019
Q3 | $604K | Hold |
2,515
| – | – | 0.2% | 118 |
|
|
2019
Q2 | $710K | Hold |
2,515
| – | – | 0.23% | 110 |
|
|
2019
Q1 | $722K | Hold |
2,515
| – | – | 0.24% | 103 |
|
|
2018
Q4 | $661K | Hold |
2,515
| – | – | 0.25% | 104 |
|
|
2018
Q3 | $689K | Hold |
2,515
| – | – | 0.22% | 113 |
|
|
2018
Q2 | $599K | Hold |
2,515
| – | – | 0.2% | 115 |
|
|
2018
Q1 | $553K | Sell |
2,515
-185
| -7% | -$43.5K | 0.19% | 121 |
|
|
2017
Q4 | $608K | Hold |
2,700
| – | – | 0.2% | 124 |
|
|
2017
Q3 | $513K | Sell |
2,700
-145
| -5% | -$27.6K | 0.17% | 135 |
|
|
2017
Q2 | $535K | Hold |
2,845
| – | – | 0.19% | 133 |
|
|
2017
Q1 | $471K | Hold |
2,845
| – | – | 0.18% | 131 |
|
|
2016
Q4 | $409K | Hold |
2,845
| – | – | 0.21% | 119 |
|
|
2016
Q3 | $357K | Hold |
2,845
| – | – | 0.19% | 133 |
|
|
2016
Q2 | $374K | Hold |
2,845
| – | – | 0.2% | 123 |
|
|
2016
Q1 | $395K | Sell |
2,845
-300
| -10% | -$40.1K | 0.22% | 124 |
|
|
2015
Q4 | $439K | Hold |
3,145
| – | – | 0.23% | 121 |
|
|
2015
Q3 | $440K | Hold |
3,145
| – | – | 0.24% | 115 |
|
|
2015
Q2 | $516K | Hold |
3,145
| – | – | 0.26% | 109 |
|
|
2015
Q1 | $486K | Buy |
3,145
+345
| +12% | +$49.1K | 0.25% | 116 |
|
|
2014
Q4 | $352K | Hold |
2,800
| – | – | 0.18% | 133 |
|
|
2014
Q3 | $335K | Sell |
2,800
-200
| -7% | -$22.9K | 0.17% | 137 |
|
|
2014
Q2 | $323K | Hold |
3,000
| – | – | 0.16% | 147 |
|
|
2014
Q1 | $299K | Hold |
3,000
| – | – | 0.16% | 149 |
|
|
2013
Q4 | $277K | Hold |
3,000
| – | – | 0.16% | 145 |
|
|
2013
Q3 | $251K | Hold |
3,000
| – | – | 0.17% | 139 |
|
|
2013
Q2 | $246K | Buy |
+3,000
| New | +$225K | 0.19% | 134 |
|
Other funds holding ELV
Regent Investment Management's ELV Position: Q4 2022 in Review
Regent Investment Management held its Elevance Health (ELV) position steady in Q4 2022 at 2,515 shares worth $1.29M. The position accounts for 0.35% of the portfolio, ranked #81.
Regent Investment Management first reported a position in ELV in Q2 2013 and has held it in 39 quarters since. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.
- Regent Investment Management held 2,515 shares of Elevance Health worth $1.29M as of Q4 2022.
- Regent Investment Management left its Elevance Health share count unchanged in Q4 2022.
- Elevance Health made up 0.35% of Regent Investment Management's portfolio in Q4 2022, its #81 holding.
- Regent Investment Management first reported a position in Elevance Health in Q2 2013 and has held it in 39 quarters since.
- 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.
Based on Regent Investment Management's 13F filing for Q4 2022, filed 26 Jan 2023.